… Kim, an international pharmaceutical company specializing in the … anti-HER2 therapy medicines for metastatic breast … trastuzumab-based therapy. NERLYNX® is a registered trademark of Puma Biotechnology … clinical trial of alisertib monotherapy for the treatment …

… the first portion of the trial (n = 20), single-patient cohorts … investigators proposed a co-treatment with trastuzumab with the goal of saturating … (n = 53) portion of the trial. For this portion of the … trial, the median age of this …

… Ib Beamion LUNG-1 trial (NCT04886804), Boehringer investigated … ’s Enhertu (trastuzumab deruxtecan) received FDA approval in August … 47;head and neck medical oncology Dr John Heymach … treatment option that addresses an unmet need for these patients.” The drug …

… University School of Medicine, presented the poster … Trials Network (ETCTN). This open label, multi-center, Phase I clinical trial … HER2 mutation. Prior treatment with trastuzumab deruxtecan was not … AZN). About Puma Biotechnology Puma Biotechnology, Inc. is a …

… Journal of Medicine. The trial previously reported … treatment for this patient population is the antibody-drug conjugate trastuzumab … review by the FDA earlier this … Spectrum Pharmaceuticals, GSK, EMD Serono, Blueprint Medicines and Chugai Pharmaceutical. He …

… clinical trials as a first-line treatment for patients … Cyramza (ramucirumab), Herceptin (trastuzumab), Rituxan (rituximab) and … to a future medical meeting. Evorpacept acts … trial failures and clinical holds by the US Food and Drug Administration (FDA …

… April 2025, the Committee for Medicinal Products for Human Use (CHMP … efficacy to Herceptin (trastuzumab). More information on biosimilar medicines can be found … with trastuzumab. Early breast cancer Dazublys is indicated for the treatment of …

… compared with the standard treatment of taxane, trastuzumab (Herceptin), and pertuzumab … the FDA, the design of this registrational trial has … study. Published in Nature Medicine, the study also … represents the first antibody-drug conjugate combined with …

… including infection. Institute medical management promptly, including … FDA-approved test. Gastric Cancer KEYTRUDA, in combination with trastuzumab … to clinical trial participation, screening and treatment, we … the impact of pharmaceutical industry regulation and …

… announced that the Committee for Medicinal Products for Human Use (CHMP … for infusion), its trastuzumab biosimilar, for the treatment of HER2-positive metastatic … range of products from bulk drug substance to fill-finish and …